These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6379124)

  • 21. Kinetics and function of tumor cytotoxic factor(s) produced by human blood monocytes activated to the tumoricidal state.
    Sone S; Lopez-Berestein G; Fidler IJ
    J Natl Cancer Inst; 1985 Mar; 74(3):583-90. PubMed ID: 3856062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of human monocytes by mediators from lymphocytes stimulated with Corynebacterium parvum.
    Hammerström J; Unsgaard G; Lamvik J
    Acta Pathol Microbiol Scand C; 1979 Jun; 87C(3):167-75. PubMed ID: 484237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergism between human recombinant gamma-interferon and muramyl dipeptide encapsulated in liposomes for activation of antitumor properties in human blood monocytes.
    Saiki I; Sone S; Fogler WE; Kleinerman ES; Lopez-Berestein G; Fidler IJ
    Cancer Res; 1985 Dec; 45(12 Pt 1):6188-93. PubMed ID: 3933823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Induction of human monocyte-mediated tumor cell killing by alpha or beta interferon].
    Utsugi T; Mutsuura S; Ogawara M; Shirahama T; Ishii K; Tsubura E; Sone S
    Gan To Kagaku Ryoho; 1985 May; 12(5):1105-10. PubMed ID: 3994398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumoricidal activity of human monocytes: evidence for cytolytic function distinct from that of NK cells.
    Kleinerman ES; Herberman RB
    J Immunol; 1984 Jul; 133(1):4-6. PubMed ID: 6373931
    [No Abstract]   [Full Text] [Related]  

  • 26. Regulation of human peripheral blood monocyte DR antigen expression in vitro by lymphokines and recombinant interferons.
    Sztein MB; Steeg PS; Johnson HM; Oppenheim JJ
    J Clin Invest; 1984 Feb; 73(2):556-65. PubMed ID: 6230374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Production and utilization of human lymphokines containing macrophage-activating factor (MAF) activity.
    Kleinerman ES; Fidler IJ
    Lymphokine Res; 1983; 2(1):7-12. PubMed ID: 6381900
    [No Abstract]   [Full Text] [Related]  

  • 28. Constitutive production and release of a lymphokine with macrophage-activating factor activity distinct from gamma-interferon by a human T-cell leukemia virus-positive cell line.
    Kleinerman ES; Zicht R; Sarin PS; Gallo RC; Fidler IJ
    Cancer Res; 1984 Oct; 44(10):4470-5. PubMed ID: 6088039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macrophages as cytotoxic effector cells.
    Lohmann-Matthes ML; Lang H; Sun D
    Immunobiology; 1982 Apr; 161(3-4):401-7. PubMed ID: 7047379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytotoxicity on tumour cells of human mononuclear phagocytes: defective tumoricidal capacity of alveolar macrophages.
    Bordignon C; Avallone R; Peri G; Polentarutti N; Mangioni C; Mantovani A
    Clin Exp Immunol; 1980 Aug; 41(2):336-42. PubMed ID: 6160006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro influence of endotoxin on human mononuclear phagocyte structure and function. 2. Enhancement of the expression of cytoststic and cytolytic activity of normal and lymphokine-activated monocytes.
    Hammerstrøm J
    Acta Pathol Microbiol Scand C; 1979 Dec; 87(6):391-9. PubMed ID: 397718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of tumoricidal properties in mouse macrophages by lymphokines encapsulated in liposomes.
    Poste G; Kirsh R; Fogler WE; Fidler IJ
    Cancer Res; 1979 Mar; 39(3):881-92. PubMed ID: 427777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid decay of tumoricidal activity and loss of responsiveness to lymphokines in inflammatory macrophages.
    Poste G; Kirsh R
    Cancer Res; 1979 Jul; 39(7 Pt 1):2582-90. PubMed ID: 87267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of human monocyte susceptibility to lymphokine-activated killer cell lysis by granulocyte-macrophage colony-stimulating factor.
    Blanchard DK; Serbousek D; Djeu JY
    Cancer Res; 1989 Sep; 49(18):5037-43. PubMed ID: 2670200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of in vitro tumoricidal activity in alveolar macrophages and monocytes from patients with lung cancer.
    Thomassen MJ; Wiedemann HP; Barna BP; Farmer M; Ahmad M
    Cancer Res; 1988 Jul; 48(14):3949-53. PubMed ID: 2838166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dissociation between tumour cell cytostatic and immuno-suppressive capacity of human monocytes activated with lymphokines.
    Unsgaard G; Hammerstrøm J; Lamvik J
    Acta Pathol Microbiol Immunol Scand C; 1982 Apr; 90(2):73-9. PubMed ID: 7080839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of tumoricidal properties in macrophages by lymphokines encapsulated in liposomes.
    Fidler IJ; Fogler WE
    Lymphokine Res; 1982; 1(3):73-7. PubMed ID: 6765335
    [No Abstract]   [Full Text] [Related]  

  • 38. Interferon as a macrophage activating factor. I. Enhancement of cytotoxicity by fresh and matured human monocytes in the absence of other soluble signals.
    Dean RT; Virelizier JL
    Clin Exp Immunol; 1983 Mar; 51(3):501-10. PubMed ID: 6342884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymphocyte supernatant-induced human monocyte tumoricidal activity: dependence on the presence of gamma-interferon.
    Sadlik JR; Hoyer M; Leyko MA; Horvat R; Parmely M; Whitacre C; Zwilling B; Rinehart JJ
    Cancer Res; 1985 May; 45(5):1940-5. PubMed ID: 3921233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative analysis of the priming effect of human interferon-gamma, -alpha, and -beta on synergism with muramyl dipeptide analog for anti-tumor expression of human blood monocytes.
    Utsugi T; Sone S
    J Immunol; 1986 Feb; 136(3):1117-22. PubMed ID: 3079797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.